RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first ...

August 20, 2025—enVVeno Medical Corporation announced that it has received a not-approvable letter from the FDA in response to its premarket app ...